Upload
others
View
9
Download
0
Embed Size (px)
Citation preview
Influenza (Pandemic)Influenza (Pandemic)
Dr Roger Gajraj
Consultant in Communicable Disease Control
HPA West Midlands EastBartholomew House142 Hagley RoadBirmingham B16 9PATel: 0121 224 4670
April 2008April 2008
Influenza
Avian influenza
Seasonal influenza
Pandemic influenza
– How, when and where
– Impact
– Spread
– Control
• Public health measures
• Workplace considerations
• Actions for individuals
Outline
Epidemic: serious outbreak in a single
area
Pandemic: epidemic spreading around
the world affecting hundreds of
thousands of people, across many
countries
Definitions
Influenza
Haemagluttinin H Protein
Enables virus to attach to host cell
15 exist in nature
H1, H2, H3: human infection
H5, H7, H9
Influenza Virus
Neuraminidase N Protein
Enables new virion release from host cell
Essential for virus replication
N1, N2: human infection
Humans only
Humans only
Humans
Birds
Mammals
Hosts
Sporadic mild illnessC
Epidemics infrequentlyB
Epidemics
PandemicsA
Disease patternsType
Influenza disease patterns
Avian influenza(“bird flu”)
Avian influenza
A disease of birds: wild and domestic
Bird saliva, nasal fluids, droppings, feathers
H5N1
• Severe
• Chickens, ducks, wild birds
• Many countries
‘Human’ avian influenza
Very small number of humans affected
- Local people with close contact with infected birds
Does NOT spread easily person-person
- Few instances where very close person-person contact may have resulted in transmission
- Person-person-STOP
No evidence of widespread asymptomatic infection
Avian influenza symptoms
Similar to ordinary flu: sudden onset
Fever (temperature of 38°C or more)
Cough
Shortness of breath
Headache
Sore throat
Sore eyes
Muscle aches
Seasonal influenza
Signs and symptoms
Abrupt onset, Fever, Cough/SOB
Also:
Malaise, Chills, Headache, Loss of appetite, Runny nose, Sneezing, Muscle aches, Sore throat
No symptoms in 50%?
Severe complications and death
Bacterial &/or viral pneumonia
Overwhelming viraemia
Annual influenza vaccine
Winter; 12,000 deaths annually
Vaccine: two A strains and one B strain
Risk groups
- Elderly (over 65s)
- Chronic illness: asthma, bronchitis, diabetes, heart, kidney,
liver, weak immunity
- Nursing and residential homes
- Carers
- Health and social care workers
Pandemic influenzahow, why, when, where?
Antigenic change
Enables influenza A viruses to cause epidemics and
pandemics
Influenza A virus surface antigens undergo frequent
changes
Minor changes - antigenic drift
Major changes - antigenic shift
Antigenic drift
New variants of prevailing strains emerge every
year
Result in seasonal flu each winter
Some years are worse than others – partly related
to degree of ‘drift’
Antigenic shift
Influenza A only
Major changes in the surface antigens
Occurs in 2 ways:
- Sudden ‘adaptive’ change during replication
- Genetic exchange (‘re-assortment’) between human & animal strains
Population will have little or no immunity to new virus from
previous exposure or vaccination
Lack of immunity allows virus to spread more rapidly and
more widely
New pandemic strain
Avian strain and Human strain
• Genetic reassortment
Human strain
• Abrupt major genetic change
Avian strain
• Adaptation in humans
Migratory water birds
New influenza strain (1)
Domestic bird
Migratory water birds Domestic
bird
New influenza strain (1)
New influenza strain (2)
New influenza strain (2)
Migratory water birds
New influenza strain (3)
Domestic bird
Migratory water birds
New influenza strain (3)
Pre-requisites for pandemic influenza
• New influenza A sub-type
• Little or no pre-existing population immunity
• Causes significant clinical illness
• Efficient person-to-person spread
H5N1
End of pandemic. Return to inter-pandemic period
Post Pandemic Period
UK Alert level1 Virus/cases only outside the UK2 Virus isolated in the UK3 Outbreak(s) in the UK4 Widespread activity across the UK
Increased and sustained transmission in general population
6
Pandemic Period
Large cluster(s) but human-to-human spread still localised
5
Small cluster(s) with limited and highly localised human-to-human transmission
4
UK not affectedUK has strong travel/trade with affected countryUK affected
Human infection(s) with a new subtype, but only rare spread to a close contact
3
Pandemic Alert Period
Animal influenza virus subtype poses substantial risk
2
UK not affectedUK has strong travel/trade with affected countryUK affected
No new influenza virus subtypes detected in humans
1
Inter-pandemic Period
Significance for the UKInternational phases
End of pandemic. Return to inter-pandemic period
Post Pandemic Period
UK Alert level1 Virus/cases only outside the UK2 Virus isolated in the UK3 Outbreak(s) in the UK4 Widespread activity across the UK
Increased and sustained transmission in general population
6
Pandemic Period
Large cluster(s) but human-to-human spread still localised
5
Small cluster(s) with limited and highly localised human-to-human transmission
4
UK not affectedUK has strong travel/trade with affected countryUK affected
Human infection(s) with a new subtype, but only rare spread to a close contact
3
Pandemic Alert Period
Animal influenza virus subtype poses substantial risk
2
UK not affectedUK has strong travel/trade with affected countryUK affected
No new influenza virus subtypes detected in humans
1
Inter-pandemic Period
Significance for the UKInternational phases
End of pandemic. Return to inter-pandemic period
Post Pandemic Period
UK Alert level1 Virus/cases only outside the UK2 Virus isolated in the UK3 Outbreak(s) in the UK4 Widespread activity across the UK
Increased and sustained transmission in general population
6
Pandemic Period
Large cluster(s) but human-to-human spread still localised
5
Small cluster(s) with limited and highly localised human-to-human transmission
4
UK not affectedUK has strong travel/trade with affected countryUK affected
Human infection(s) with a new subtype, but only rare spread to a close contact
3
Pandemic Alert Period
Animal influenza virus subtype poses substantial risk
2
UK not affectedUK has strong travel/trade with affected countryUK affected
No new influenza virus subtypes detected in humans
1
Inter-pandemic Period
Significance for the UKInternational phases
End of pandemic. Return to inter-pandemic period
Post Pandemic Period
UK Alert level1 Virus/cases only outside the UK2 Virus isolated in the UK3 Outbreak(s) in the UK4 Widespread activity across the UK
Increased and sustained transmission in general population
6
Pandemic Period
Large cluster(s) but human-to-human spread still localised
5
Small cluster(s) with limited and highly localised human-to-human transmission
4
UK not affectedUK has strong travel/trade with affected countryUK affected
Human infection(s) with a new subtype, but only rare spread to a close contact
3
Pandemic Alert Period
Animal influenza virus subtype poses substantial risk
2
UK not affectedUK has strong travel/trade with affected countryUK affected
No new influenza virus subtypes detected in humans
1
Inter-pandemic Period
Significance for the UKInternational phases
Warning signs!
WHO experts believe signs of another pandemic are
increasing
Rapid and continuing spread of H5N1 avian influenza,
outbreaks occurring at the same time in several
countries, historically unprecedented
Linked to human cases of Avian H5N1 flu
The virus may be adapting to infect people more readily
History of Influenza
412 BC: first mentioned by Hippocrates
1580: first pandemic described
1580 – 1900: 28 pandemics
What do we know about pandemic influenza
Geographic spread: 1968-69 Hong Kong pandemic
07/68
08/68
09/68
09/68
09/68
09/68
06/69
09/68
01/69
C.W. Potter, Textbook of Influenza, 1998
AsiaEurope
Africa
Australia
South
America
North
America
1918/19 H1N1
- 3 distinct waves: spring 1918; autumn 1918; winter 1919
- 2nd wave the largest and highest case fatality
1957/58 H2N2
- 2nd wave very small compared to 1st
1968/69/70 H3N2
- 1st wave winter 1968/69
- 2nd wave 1969/70 more severe
Pandemic waves
0
20
40
60
80
100
120
140
160
0-4
5-9
10-1
4
15-1
9
20-2
4
25-2
9
30-3
4
35-3
9
40-4
4
45-4
9
50-5
4
55-5
9
60-6
4
65-6
9
70-7
4
75-7
9
80-8
4
85+
Dea
th R
ate
per
1,0
00
4st quarter
1st quarter
Age specific influenza death rates among females in England & Wales during 1st and 4th quarters of 1918
Ministry of Health, GB, 1919
Estimating health impact &effectiveness of interventions
UNPREDICATABILITY the key lesson
Role of modelling
to estimate possible range of effects
to suggest which responses are robust over the range of uncertainty
Modelling
data fed into the models
assumptions made in the model design
Pandemic flu modelling
little data
wide range of plausible assumptions
Pandemic influenzaIMPACT
Planning assumptions (1)
Pandemic highly probable
Could occur at any time in the future
Could occur at any time of the year
Likely origin: SE Asia, Middle East or Africa
Spread to the UK in 2-4 weeks
Further 1-2 weeks until widespread UK activity
One or more waves; initial wave 3-5 months
Subsequent waves weeks or months apart
Subsequent waves possibly more severe than first
Planning assumptions (2): impact
All ages likely to be affected
Children and fit adults may be greater risk
Cases absent from work for up to 10 days
Reasonable worst case:
- 50% clinical attack rate (22% in peak week)
- 30% will need GP care
- 4% will require hospitalisation (25% of these to ITU)
- average hospitalisation for 6 days (10 days for ITU)
- 2.5% case mortality
What an influenza pandemic will mean for the UK
High levels of illness
Intense pressure on health services
Disruption to many aspects of daily life
Many deaths
Impact: University of Birmingham
Population of students and staff: 32,000
16,000 cases
9,120 need GP care
640 hospitalised cases
400 deaths
Deaths from seasonal, avian, & pandemic influenza
Previous pandemics (E&W)
1918/19 (H1N1; ‘Spanish flu’): 198,000
1957/58 (H2N2; ‘Asian flu’): 37,500
1968/69/70 (H3N2; ‘Hong Kong flu’): 78,000
Seasonal flu (E&W)
Annual: 12,000
1989/90: 26,000
Avian influenza (World)
1995 (UK; H7N7): 0 (1)
1997 (Hong Kong; H5N1): 6 (18)
1998 (China; H9N2) : 0 (5)
1999 (Hong Kong; H9N2) : 0 (2)
2003 (Hong Kong; H5N1): 1 (2)
2003 (Canada; H7N3): 0 (2)
2003 (Holland; H7N7) : 1 (84)
2003 (Hong Kong; H9N2) : 0 (1)
From 2003 (E/SE Asia; H5N1) : 238 (378) 03/04/08
Next pandemic (UK)
Worst case: 750,000 ?
Pandemic influenzaSPREAD
Incubation period: 1-4 days
Infectious period
- 5 days from onset
- 7 days in children
Asymptomatic people can spread infection
Highly transmissable: R0 1.4-1.8
Transmission
Large droplets fall
on people, surfaces,
bed, clothes
Courtesy of CDC
Mode of spread
- Direct: droplet spread
- Indirect: contact with
contaminated surfaces
- Airborne
Transmission (2)
Virus survivalHard surfaces:
Detectable up to 72hr
Viable quantities transferable and detectable on hands: 24hr
Soft surfaces/furnishings:
Detectable up to 24hr
Viable quantities transferable & detectable on hands: 15mins
Survival on hands after transfer: 5 minutes
Easily inactivated on surfaces:
Household cleaners, bleach solutions, standard detergents
Easily inactivated on hands:
Soap, water and drying
OR alcohol based gels/solutions (30 sec)
Ref: Guidance for cleaners
Pandemic influenzaCONTROL/ PUBLIC HEALTH MEASURES
Principles of pandemic response
Business continuity
Health care
Responding to many deaths
Communicable disease control
- on an epidemic scale
Supporting health services
- eg social care and policing
Activities to support the above
- eg surveillance, HR policies
Options for population-wide interventions
Pre-pandemic vaccine
Schools closures
Travel restrictions
Action at UK ports
Restrictions of mass public gatherings
Cases: home isolation; hygiene; infection control
Wearing of masks by the public
Antivirals; pandemic-specific vaccine
Antiviral drugs
UK stockpile of 14.6 million courses
Likely the only early available medical countermeasure
Prevent flu virus from reproducing
Effective if course started within 48 hours
National Flu Line service
Predominantly for treatment (not prevention)
- If available stock < number of cases, treat priority groups
Antiviral drugs (2)
NOT a ‘magic bullet’
- Shorten the illness by one day
- Reduce severity of symptoms
Treating all cases in a pandemic might
- Decrease attack rate by one third?
- Reduce hospitalisations by ~50%?
- Decrease number of deaths
BUT: Unknown if it will be effective vs pandemic strain
Is there a vaccine?Likely to be the most effective intervention against influenza
New virus therefore no vaccine
- ‘Ordinary’ flu vaccine or past flu jab: no protection
Vaccine cannot be made until virus identified
- Will not be available in early stages
- 4-6 months to produce, possibly longer
Initial available vaccine will be given to nationally agreed
priority groups
Ongoing work/ research to reduce production time
Aim: immunise whole population
Pandemic influenzaWORKPLACE CONSIDERATIONS
“Business as usual, for as long and as far
as that is possible”. Pandemic flu. A national
framework for responding to an influenza pandemic. DH,
Cabinet Office. Nov 2007
Absenteeism
Personal illness
Carer responsibilities
- Caring for ill relatives
- School closures
Bereavement
Fear of infection
Other factors
- eg transport disruption
Absenteeism (2)
Personal illness: absent from work up to 10 days
50% workforce might require 7-10 days off work sometime
Staff absenteeism will reflect pandemic profile
- Peak absenteeism lasting 2-3 weeks
- 15-20% absenteeism at the peak
- 30-35% absenteeism at the peak for small teams/
organisations (5-15 staff)
Estimating staff absence levels
- Proportion of staff with childcare or carer responsibilities
- ‘Normal’ absence levels
Health and Safety at Work
The Law
- Health and Safety at Work etc Act 1974
- Management of Health and Safety at Work Regulations 1999
- Control of Substances Hazardous to Health Regulations (COSHH)
Scenarios
- Exposure as a direct consequence of work (eg research; HCW;
cleaners; etc)
- Indirect Health and Safety considerations (eg staff redployment;
lone/ home working; etc)
Health and Safety at Work (2)
Local risk assessments
- Opportunity to educate and reassure
- Joint assessments: employers, employees, trade unions
- Risk of greater exposure than in the community?
- Vulnerable staff at particular risk
- Proportionate containment and protection measures
Health and Safety at Work (3)
Changes to working arrangements
- eg flexible hours; working from home
- staff redeployment to unfamiliar tasks: training
- Working Time Regulations 1998
Infection control considerations
- eg reduce close contact; physical barriers; enhanced
cleaning; hygiene facilities; PPE
Health and Safety at Work (4)
Employees who develop symptoms at work
- face mask; go home; avoid public transport
Employees who call in sick
- stay at home; reassure; follow-up contact
Make best use of recovered staff
Closure of educational facilities
Schools and early years/childcare settings
- Depending on pandemic impact, Govt may advise closure
- Closure from arrival of the first confirmed cases in the
LRF area, until the local epidemic is over
Further and higher education
- No Govt plans to advise closure
- Each institution to decide how it operates: based on risk
assessment and individual circumstances
Pandemic influenzaACTIONS FOR INDIVIDUALS
If you do catch the flu
Stay at home and rest
Symptomatic relief
- aspirin, ibuprofen, paracetamol
- follow the instructions
- under 16 yr: no aspirin
- under 2 yr: many cough and cold medicines dangerous
Drink plenty of fluids
Wear a disposable face mask if it is absolutely essential
to go out (eg to go to hospital)
Protect yourself and others
Cover nose and mouth with a tissue when coughing or sneezing
Dispose of dirty tissues promptly & carefully – bag and bin them
Wash hands frequently with soap & warm water to reduce virus
spread from hands to face or other people, especially
after blowing nose or disposing of tissues
Clean frequently touched hard surfaces (eg kitchen worktops,
door handles) regularly using normal cleaning products
Avoid crowded gatherings where possible, especially in
enclosed spaces
Make sure that children follow this advice
END